Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010

International Journal of Antimicrobial Agents

Volumn 39, Issue 6, 2012, Pages 490-495

  Hawser, Stephen P ^a   Bouchillon, Samuel K ^b   Hackel, Meredith ^b   Chen, Minjun ^c   Kim, Eui Chong ^d  

^a International Health Management Associates Europe Sàrl   (Switzerland)

^b International Health Management Associates   (United States)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d Seoul National University Hospital   (South Korea)

Author keywords

Asia Pacific; Susceptibility; TEST; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFEPIME; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ASIA; CONFERENCE PAPER; DRUG ACTIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PACIFIC ISLANDS; PRIORITY JOURNAL; SERRATIA MARCESCENS; SPECIES DIFFERENCE; TREND STUDY;

ANTI-BACTERIAL AGENTS; ASIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POPULATION SURVEILLANCE; SPECIES SPECIFICITY;

EID: 84860446778     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.02.018     Document Type: Conference Paper

References (16)

1. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:481-98.
2. G.V. Bochicchio, F. Baquero, P.R. Hsueh, D.L. Paterson, F. Rossi, and T.A. Snyder In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends) Surg Infect (Larchmt) 7 2006 537 545 (Pubitemid 46348304)
3. Y.H. Chen, P.R. Hsueh, R.E. Badal, S.P. Hawser, D.J. Hoban, and S.K. Bouchillon Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria J Infect 62 2011 280 291
4. R.K. Doshi, G. Patel, R. Mackay, and F. Wallach Healthcare-associated infections: epidemiology, prevention, and therapy Mt Sinai J Med 76 2009 84 94
5. S.P. Hawser, R.E. Badal, S.K. Bouchillon, D.J. Hoban SMART India Working Group Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008 J Med Microbiol 59 2010 1050 1054
6. K.C. Kuo, Y.H. Shen, and K.P. Hwang Clinical implications and risk factors of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan J Microbiol Immunol Infect 40 2007 248 254
7. S.R. Lockhart, M.A. Abramson, S.E. Beekmann, G. Gallagher, S. Riedel, and D.J. Diekema Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004 J Clin Microbiol 45 2007 3352 3359 (Pubitemid 47585661)
8. F. Rossi, F. Baquero, P.R. Hsueh, D.L. Paterson, G.V. Bochicchio, and T.A. Snyder In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends) J Antimicrob Chemother 58 2006 205 210 (Pubitemid 44295010)
9. D.J. Diekema, M.A. Pfaller, J. Turnidge, J. Verhoef, J. Bell, and A.C. Fluit Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998 Microb Drug Resist 6 2000 213 221
10. S.P. Hawser, S.K. Bouchillon, D.J. Hoban, M. Dowzicky, and T. Babinchak Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009 Int J Antimicrob Agents 37 2011 219 224
11. S.S. Jean, and P.R. Hsueh High burden of antimicrobial resistance in Asia Int J Antimicrob Agents 37 2011 291 295
12. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). Document M100-S20-U. Wayne, PA: CLSI; 2010.
14. M.W. Garrison, R. Mutters, and M.J. Dowzicky In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007 Diagn Microbiol Infect Dis 65 2009 288 299
15. F. Rossi, P. García, B. Ronzon, D. Curcio, and M.J. Dowzicky Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics Braz J Infect Dis 12 2008 405 415
16. S.K. Bouchillon, J.R. Iredell, T. Barkham, K. Lee, and M.J. Dowzicky Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) Int J Antimicrob Agents 33 2009 130 136